论文部分内容阅读
目的研究并探讨新生儿肺炎应用抗生素联合氨溴索口服溶液治疗的效果分析。方法选取我院自2013年10月至2014年10月收治的新生儿肺炎患者130例,将其作为临床研究对象,针对患者采用两种不同的方式进行治疗。其中对照组采用抗生素美洛西林舒巴坦钠进行治疗,试验组采用抗生素联合氨溴索口服液进行治疗。结果试验组采用抗生素联合氨溴索口服液治疗的总有效为95.4%,,对照组采用抗生素美洛西林舒巴坦钠治疗的总有效为69.2%,两组差距较为明显,P<0.05,具有统计学意义。结论采用抗生素联合氨溴索口服液联合治疗新生儿肺炎,临床效果较为显著。患者治疗后效果确切,患者以及患者家属较为满意,因此这治疗方式值得我们在临床上大力推荐。
Objective To study and investigate the effect of antibiotic combined with ambroxol oral solution in the treatment of neonatal pneumonia. Methods A total of 130 cases of neonatal pneumonia admitted from October 2013 to October 2014 in our hospital were selected as clinical research subjects and treated with two different ways for patients. The control group was treated with antibiotic mezlocillin and sulbactam sodium, and the experimental group was treated with antibiotics and ambroxol oral solution. Results The total effective rate of antibiotic combined with ambroxol in the experimental group was 95.4%. The total effective rate of the control group treated with the antibiotic mezlocillin and sulbactam sodium was 69.2%. The difference between the two groups was significant (P <0.05) Statistical significance. Conclusion The combination of antibiotics and ambroxol oral solution in the treatment of neonatal pneumonia, the clinical effect is more significant. After treatment, the exact effect of patients, patients and their families are more satisfied, so this treatment is worth our highly recommended in the clinic.